Skip to main content

Peer Review reports

From: Interleukin-6 mediates resistance to PI3K-pathway–targeted therapy in lymphoma

Original Submission
22 Mar 2019 Submitted Original manuscript
20 May 2019 Reviewed Reviewer Report - Jui-Chieh Chen
29 May 2019 Reviewed Reviewer Report - Basudev Chowdhury
30 Jul 2019 Author responded Author comments - Joo Hyun Kim
Resubmission - Version 2
30 Jul 2019 Submitted Manuscript version 2
13 Aug 2019 Author responded Author comments - Joo Hyun Kim
Resubmission - Version 3
13 Aug 2019 Submitted Manuscript version 3
Publishing
19 Aug 2019 Editorially accepted
10 Oct 2019 Article published 10.1186/s12885-019-6057-7

You can find further information about peer review here.

Back to article page